Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Bowel functions and bile Acids in patients with irritable bowel syndrome

May's issue of Clinical Gastroenterology & Hepatology investigates bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.

News image

There is an unclear relationship among bowel symptoms, excretion of unconjugated fecal bile acid, and colonic transit in irritable bowel syndrome.

Dr Andrea Shin and colleagues measured total and main individual unconjugated fecal bile acid in fecal samples of patients with irritable bowel syndrome (IBS), and assessed relationships among stool frequency or consistency, fecal unconjugated fecal bile acid, and colonic transit.

The team examined 30 healthy volunteers, 31 subjects with irritable bowel syndrome with diarrhea, and 30 with irritable bowel syndrome with constipation.

The patients were placed on 4-day diets containing 100 g fat.

The researchers measured stool characteristics, total fecal unconjugated fecal bile acid and fat levels, and overall colonic transit. 

The team assessed univariate associations of total and individual levels of fecal unconjugated fecal bile acid with phenotype using the Kruskal-Wallis test, and associations between endpoints were assessed using Spearman correlations.

The research team assessed relationships between stool, colonic transit, and fecal total and secretory unconjugated fecal bile acid.

Total fecal unconjugated fecal bile acid was associated with phenotype
Clinical Gastroenterology and Hepatology

There was a significant association between total fecal unconjugated fecal bile acid and phenotype.

The team found that the association was greater for irritable bowel syndrome-D than irritable bowel syndrome-C, compared with controls.

The doctors noted that fecal levels of primary unconjugated fecal bile acid were higher in subjects with irritable bowel syndrome-D, compared with controls.

Levels of fecal secretory unconjugated fecal bile acid were lower in subjects with irritable bowel syndrome-C compared with controls, whereas levels of the nonsecretory unconjugated fecal bile acid, lithocholic acid, were higher.

The researchers found significant univariate associations between stool number and form and total fecal unconjugated fecal bile acid, fecal fat, and colonic transit at 24 and 48 hours after eating.

In the regression models, the relative contribution of colonic transit was consistently greater, and largely independent of the contribution of bile acids.

Dr Shin's team commented, "Measurements of individual unconjugated fecal bile acids identify changes associated with stool characteristics in patients with irritable bowel syndrome."

"These effects are independent of the effects of colonic transit."

Clin Gastroenterol Hepatol 2013
13 May 2013

Go to top of page Email this page Email this page to a colleague

 20 April 2015

Advanced search
 20 April 2015 
IBS after traveller's diarhea
 20 April 2015 
Adherence to Hep C treatments
 20 April 2015 
Economic impact of C. diff infection
 17 April 2015 
PNPLA3 polymorphisms and NAFLD risk
 17 April 2015 
Synchronous colorectal advanced neoplasia
 17 April 2015 
MELD score and colorectal resection
 16 April 2015 
Bleeding risk in colonic diverticulosis
 16 April 2015 
Minority use of high-volume hospitals for colorectal cancer
 16 April 2015 
Sleep and IBD
 15 April 2015 
Treatment of hepatocellular carcinoma
 15 April 2015 
Score predicts malignant bile duct obstruction
 15 April 2015 
Increased risk of Barrett esophagus
 14 April 2015 
Improving colorectal cancer screening uptake
 14 April 2015 
Colorectal cancer presenting under the age of 50
 14 April 2015 
Functional constipation vs constipation predominant IBS
 13 April 2015 
Fecal transplant for C. difficile
 13 April 2015 
CRP and acute diverticulitis
 13 April 2015 
Immune based treatments for HCC
 10 April 2015 
Hypnotherapy for IBS
 10 April 2015 
Adjuvant therapy after rectal cancer
 10 April 2015 
Viral outcomes in HCV infection
 09 April 2015 
Male IBD patients wishing to conceive
 09 April 2015 
Screening programs based on the fecal immunochemical test
 09 April 2015 
Management of esophageal food impaction
 08 April 2015 
Nonceliac gluten sensitivity
 08 April 2015 
Ambulatory hemorrhoidal surgery
 08 April 2015 
Iron fortification and gut inflammation
 07 April 2015 
Endoscopic managements of GI bleeds
 07 April 2015 
Interventions for eosinophilic esophagitis
 07 April 2015 
Treatment of Hep C virus
 06 April 2015 
Treatment for rectal cancer
 06 April 2015 
Risk stratifying Barrett's esophagus
 06 April 2015 
Cost-effectiveness of HCV
 03 April 2015 
Predicting advanced cancer in Barrett's
 03 April 2015 
Vitamin D deficiency and Hep B outcomes
 03 April 2015 
Hepatocellular carcinoma surveillance in cirrhosis
 02 April 2015 
Physical activity and NAFLD
 02 April 2015 
Genetic risk for Crohn's disease
 02 April 2015 
EUS for detection of pancreatic neuroendocrine tumors
 01 April 2015 
Obeticholic acid in primary biliary cirrhosis
 01 April 2015 
Analysis of liver fibrosis
 01 April 2015 
Mortality rates for upper GI bleeds
 31 March 2015 
HCV-HIV co-infection combination therapy
 31 March 2015 
Placement of nasoenteral feeding tubes
 31 March 2015 
Hepatic fat and gallbladder polyps
 30 March 2015 
Minimally invasive approach in colorectal procedures
 30 March 2015 
Prevalence of IBD in USA residents of Indian ancestry
 30 March 2015 
Treatment of pediatric IBD
 27 March 2015 
Screening for fecal incontinence
 27 March 2015 
Deep remission in Crohn's disease
 27 March 2015 
Sexual functioning in IBD
 26 March 2015 
Antimicrobial therapy in cirrhosis with spontaneous bacterial peritonitis
 26 March 2015 
Metformin as a chemopreventive agent for Barrett's
 26 March 2015 
Survival of untreated hepatocellular carcinoma
 25 March 2015 
Genetics and Crohn's disease
 25 March 2015 
Mortality in Barrett’s–related T1 esophageal adenocarcinoma
 25 March 2015 
Cytomegalovirus and IBD
 24 March 2015 
Prevention of colorectal cancer after screening
 24 March 2015 
Functional GI disorders and body mass index
 24 March 2015 
Quality of life in children with fecal incontinence

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us